Unknown

Dataset Information

0

Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50.

ABSTRACT: Arrhythmogenic Cardiomyopathy (ACM) is an inherited cardiac disease characterized by arrhythmias and fibro-fatty replacement in the ventricular myocardium. Causative mutations are mainly reported in desmosomal genes, especially in plakophilin2 (PKP2). Here, using a virus-free reprogramming approach, we generated induced pluripotent stem cells (iPSCs) from skin fibroblasts of one ACM patient carrying the frameshift heterozygous PKP2 mutation c.2569_3018del50. The iPSC line (EURACi004-A) showed the typical morphology of pluripotent cells, possessed normal karyotype and exhibited pluripotency markers and trilineage differentiation potential, including cardiomyogenic capability. Thus, this line can represent a human in vitro model to study the molecular basis of ACM.

SUBMITTER: Ermon B 

PROVIDER: S-EPMC6189521 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50.

Ermon Benedetta B   Volpato Claudia B CB   Cattelan Giada G   Silipigni Rosamaria R   Di Segni Marina M   Cantaloni Chiara C   Casella Michela M   Pramstaller Peter P PP   Pompilio Giulio G   Sommariva Elena E   Meraviglia Viviana V   Rossini Alessandra A  

Stem cell research 20180906

Arrhythmogenic Cardiomyopathy (ACM) is an inherited cardiac disease characterized by arrhythmias and fibro-fatty replacement in the ventricular myocardium. Causative mutations are mainly reported in desmosomal genes, especially in plakophilin2 (PKP2). Here, using a virus-free reprogramming approach, we generated induced pluripotent stem cells (iPSCs) from skin fibroblasts of one ACM patient carrying the frameshift heterozygous PKP2 mutation c.2569_3018del50. The iPSC line (EURACi004-A) showed th  ...[more]

Similar Datasets

Unknown Derivation of induced pluripotent stem cells from orangutan skin fibroblasts.
| S-EPMC4609060 | biostudies-literature
Unknown AAV9:PKP2 improves heart function and survival in a Pkp2-deficient mouse model of arrhythmogenic right ventricular cardiomyopathy.
| S-EPMC10948840 | biostudies-literature
Unknown Identification of a PKP2 gene deletion in a family with arrhythmogenic right ventricular cardiomyopathy.
| S-EPMC3798844 | biostudies-literature
Unknown PKP2 and DSG2 genetic variations in Latvian arrhythmogenic right ventricular dysplasia/cardiomyopathy registry patients.
| S-EPMC6280287 | biostudies-other
Unknown Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying heterozygous FLNC mutations.
| S-EPMC10871033 | biostudies-literature
Unknown Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients.
| S-EPMC9681708 | biostudies-literature
Unknown Pathogenic variants in plakophilin-2 gene (PKP2) are associated with better survival in arrhythmogenic right ventricular cardiomyopathy.
| S-EPMC8571136 | biostudies-literature
Unknown Stop-gain mutations in PKP2 are associated with a later age of onset of arrhythmogenic right ventricular cardiomyopathy.
| S-EPMC4072667 | biostudies-literature
Transcriptomics PKP2 Gene Therapy Improves Heart Function and Reduces Mortality in a Pkp2-deficient Mouse Model of Arrhythmogenic Right Ventricular Cardiomyopathy
2024-02-23 | GSE253226 | GEO
Unknown Clinical and Molecular Data Define a Diagnosis of Arrhythmogenic Cardiomyopathy in a Carrier of a Brugada-Syndrome-Associated PKP2 Mutation.
| S-EPMC7288341 | biostudies-literature